Evaluating the Safety and Immunogenicity of a Live Attenuated Virus Vaccine to Prevent Influenza H3N2v Disease
Clinical trial NCT02883426 · TERMINATED
Trial details
- NCT number
- NCT02883426
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2017-01-05
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.